ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355644 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355644; 2) Community: the network communities that were significantly associated with the response to NSC 355644; 3) Molecule: the relationships between components within communities and NSC 355644; 4) MDR: the compounds that were significantly associated with the NSC 355644.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0430505868034761 0.10861008
NSC 756053 Null 0.0430505868034761 0.078858254
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0430505868034761 -0.086404197
NSC 121713 Null 0.0430505868034764 -0.13272323
NSC 179187 Salasdine 0.0430505868034764 0.24134596
NSC 241494 Null 0.0430505868034764 0.002434335
NSC 249992 M-AMSA 0.0430505868034764 0.82841229
NSC 357704 Cyanomorpholinodoxorubicin 0.0438391811600409 0.52992878
NSC 367416 Null 0.0438391811600409 0.085737822
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.0438391811600409 0.083418155
Total:45  Current:38    [First] [Prev] [Next] [Last]